Ensysce Biosciences, Inc.
ENSC
$2.17
-$0.30-12.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 211.69% | 183.64% | -72.76% | 140.45% | -64.30% |
| Total Receivables | 27.15% | 1,555.34% | 108.36% | -66.75% | -64.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.38% | -18.50% | -19.39% | -13.45% | -6.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 145.80% | 350.62% | -49.18% | -33.92% | -58.31% |
| Total Current Assets | 133.51% | 229.63% | -57.99% | 39.34% | -56.81% |
|
|
|||||
| Total Current Assets | 133.51% | 229.63% | -57.99% | 39.34% | -56.81% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -39.74% | -36.17% | -33.17% | -30.61% | -28.45% |
| Total Assets | 106.68% | 191.57% | -56.03% | 29.61% | -53.98% |
|
|
|||||
| Total Accounts Payable | -29.90% | 114.71% | -62.18% | -38.57% | -34.23% |
| Total Accrued Expenses | 1.14% | -41.22% | -52.89% | -82.69% | -75.64% |
| Short-term Debt | -64.70% | -- | -- | -- | -79.97% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -33.78% | 37.99% | -48.09% | -58.85% | -64.78% |
|
|
|||||
| Total Current Liabilities | -33.78% | 37.99% | -48.09% | -58.85% | -64.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -64.70% | -- | -- | -- | -79.97% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -61.74% | -89.51% | -79.87% | -80.94% | -91.49% |
| Total Liabilities | -34.00% | 36.10% | -48.68% | -59.34% | -66.12% |
|
|
|||||
| Common Stock & APIC | 9.91% | 11.17% | 7.51% | 13.35% | 13.07% |
| Retained Earnings | -6.57% | -6.71% | -9.78% | -10.21% | -9.58% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1,248.47% | 365.17% | -56.11% | 2,149.01% | 91.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,248.47% | 365.17% | -56.11% | 2,149.01% | 91.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -0.03% | -0.34% | -0.71% | -2.95% | -4.19% |
| Total Equity | 618.95% | 468.34% | -60.99% | 2,344.49% | 83.84% |
|
|
|||||